Lido Advisors LLC Sells 1,491 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Lido Advisors LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 17.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,024 shares of the company's stock after selling 1,491 shares during the period. Lido Advisors LLC's holdings in HCA Healthcare were worth $2,108,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of HCA. Whipplewood Advisors LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth $31,000. Tidemark LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth $36,000. Activest Wealth Management raised its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. lifted its stake in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after acquiring an additional 50 shares during the period. Finally, Legacy Investment Solutions LLC lifted its position in shares of HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after purchasing an additional 95 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Stock Up 1.2 %

HCA stock traded up $4.28 during midday trading on Tuesday, hitting $353.66. 323,904 shares of the company's stock were exchanged, compared to its average volume of 1,393,476. The stock has a market capitalization of $87.07 billion, a price-to-earnings ratio of 16.12, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The firm has a 50 day moving average price of $332.39 and a 200-day moving average price of $329.21. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same quarter in the previous year, the firm posted $5.36 EPS. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.81%. The ex-dividend date is Monday, June 16th. HCA Healthcare's payout ratio is 12.81%.

Analyst Upgrades and Downgrades

Several brokerages have commented on HCA. StockNews.com upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Royal Bank of Canada lowered their price target on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Guggenheim began coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Truist Financial reduced their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, Barclays reduced their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $381.13.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.